zoledronic acid has been researched along with Minimal Disease, Residual in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvet, M; Hayashi, K; Hiroshima, Y; Hoffman, RM; Kimura, H; Matsumoto, Y; Miwa, S; Sugimoto, N; Tsuchiya, H; Uehara, F; Yamamoto, M; Yamamoto, N; Yano, S; Zhang, Y | 1 |
| Dalla-Pozza, L; Little, D; Munns, C; Padhye, B | 1 |
| Blohmer, JU; Burchardi, N; Costa, SD; Denkert, C; Dubsky, P; Fasching, PA; Gerber, B; Hanusch, C; Hilfrich, J; Huober, J; Jackisch, C; Kümmel, S; Loibl, S; Mehta, K; Paepke, S; Rezai, M; Schneeweiss, A; Tesch, H; Untch, M; von Minckwitz, G; Zahm, DM | 1 |
| Bell, R; Burkinshaw, R; Cameron, D; Coleman, RE; Dodwell, D; Gil, M; Keane, MM; Marshall, SJ; Passos-Coelho, JL; Ritchie, D; Thorpe, H; Wheatley, D; Winter, MC | 1 |
3 trial(s) available for zoledronic acid and Minimal Disease, Residual
| Article | Year |
|---|---|
Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Imidazoles; Incidence; Magnetic Resonance Imaging; Male; Neoplasm, Residual; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Zoledronic Acid | 2016 |
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29).
Topics: Adult; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Disease-Free Survival; Female; Humans; Imidazoles; Middle Aged; Neoplasm, Residual; Zoledronic Acid | 2016 |
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm, Residual; Zoledronic Acid | 2010 |
1 other study(ies) available for zoledronic acid and Minimal Disease, Residual
| Article | Year |
|---|---|
Fluorescence-guided surgery of prostate cancer bone metastasis.
Topics: Adenocarcinoma; Animals; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Disease-Free Survival; Green Fluorescent Proteins; Humans; Imidazoles; Luminescent Proteins; Lymphatic Metastasis; Male; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm, Residual; Optical Imaging; Prostatic Neoplasms; Red Fluorescent Protein; Zoledronic Acid | 2014 |